No Data
No Data
Vicarious Surgical CEO Sells Shares Worth $802 to Cover Tax Obligations
Vicarious Surgical CFO Sells Shares to Cover Tax Obligations
Vicarious Surgical to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Encision Signs Master Services Agreement With Vicarious Surgical Inc.
Morgan Stanley Maintains Vicarious Surgical(RBOT.US) With Hold Rating, Cuts Target Price to $6.5
Express News | Piper Sandler Maintains Neutral on Vicarious Surgical, Adjusts Price Target To $12 From $30 (1-for-30 Reverse Stock Split)